Horizon Pharma | HZNP - Ebitda



Ebitda Veränderung Datum
AbbVie USD 5.37B 1.85B 2025-12
ALKERMES USD 80.26M 20.05M 2026-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bausch Health Companies USD 837M 94M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 12.14B 4.26B 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 6.48B 1.19B 2026-06
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Prestige Brands USD 90.82M 3.99M 2025-12
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
Takeda JPY 150.25B 297.88B 2026-03
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03
Zoetis USD 939M 101M 2025-12